Can probiotics, particularly limosilactobacillus fermentum uco-979c and lacticaseibacillus rhamnosus uco-25a, be preventive alternatives against sars-cov-2?

HIGHLIGHTS

  • who: Hu00e9ctor Valdebenito-Navarrete and collaborators from the Laboratory of Bacterial Pathogenicity, Department of Microbiology, Faculty of Biological Sciences, Universidad de, have published the research work: Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2?, in the Journal: (JOURNAL) of 15/02/2021
  • how: This review based on articles patents and an in silico analysis aims to address the present knowledge of the COVID-19 disease its symptomatology and the possible beneficial effects for patients if probiotics with the characteristics of immunobiotics are used to . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?